CLWT in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CLWT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Euro Tech Holdings helps businesses, laboratories and government agencies buy equipment for testing, monitoring and controlling water quality and industrial processes. Through its Hong Kong subsidiary Far East, it buys manufacturers’ products for resale, helps customers select equipment and provides technical and after-sales support. Distribution supplies most revenue, with scientific instruments the largest product category and power and process-control equipment another major line. Almost all revenue comes from mainland China and Hong Kong.
Water-treatment engineering is also a substantial business. Pact-Yixing supplies industrial water and wastewater-treatment projects, mainly to multinational manufacturers’ facilities in mainland China. It also manufactures systems that treat ships’ ballast water, selling to shipowners, shipyards and port operators. Engineering demand depends on customers funding environmental-compliance projects; ballast-water equipment demand is tied to maritime environmental rules. As vessel retrofit demand matures, the company plans to put more emphasis on port treatment systems.
The distribution business depends on access to manufacturers’ products, with Thermo Fisher Scientific Group and Stanford Research Systems among its largest suppliers. Some suppliers also sell directly to its customers or through competing distributors. A small group of customers supplies a substantial share of revenue. U.S. export controls can prohibit sales to restricted Chinese customers or require licenses for certain equipment, limiting which products the company can supply and to whom.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Euro Tech’s results depend on scientific-instrument spending in Hong Kong and mainland China, access to suppliers including Stanford Research Systems and Hach, and demand for industrial wastewater and ballast-water treatment.
Euro Tech depends on Thermo Fisher Scientific for scientific instruments to resell; Thermo Fisher accounted for 32% of its purchases in Fiscal 2025. Watch whether Euro Tech retains access to that supply, since losing a major supplier could hurt its instrument sales to government agencies, research institutions and laboratories.
Thermo Fisher Scientific, Inc. earningsTMO
Thermo Fisher’s report will help readers judge whether the supplier that accounted for 32% of Euro Tech’s purchases can keep providing the scientific instruments Euro Tech resells.
Read Thermo Fisher’s report for evidence about scientific-instrument supply and the business behind it. If supply and the related business remain steady, Euro Tech has a firmer basis for continuing sales to government agencies, research institutions and laboratories. If supply is constrained, Euro Tech’s instrument sales that depend on this supplier could be disrupted.